Chemoradiotherapy in pancreatic carcinoma
Abstract: Pancreatic cancer patients present late in their course and surgical resection as a modality of treatment is of limited value. Majority develop loco-regional failure and distant metastasis, therefore, adjuvant therapy comprising of radiotherapy and chemotherapy are useful treatment options to achieve higher loco-regional control. Specialized irradiation techniques like intra-operative radiotherapy that help to increase the total tumor dose have been used, however, controvertible survival benefit was observed. Various studies have shown improved median and overall survival with chemoradiotherapy for advanced unresectable pancreatic carcinoma. The role of new agents such as topoisomerase I inhibitors also needs further clinical investigations.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Chemoradiotherapy in pancreatic carcinoma ; volume:30 ; number:02 ; year:2009 ; pages:55-60
Indian journal of medical & paediatric oncology ; 30, Heft 02 (2009), 55-60
- Contributor
-
Pathy, Sushmita
Chander, Subhash
- DOI
-
10.4103/0971-5851.60049
- URN
-
urn:nbn:de:101:1-2022031216585669387367
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pathy, Sushmita
- Chander, Subhash
Other Objects (12)
Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy
A case of perforation of a pancreatic duct by a pancreatic stent during chemoradiotherapy for pancreatic head cancer: a case report
Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy > 40 Gy after systemic treatment
Verrucous carcinoma of the esophagus with complete response after chemoradiotherapy
Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy
Case reports: chemoradiotherapy for locally advanced neuroendocrine carcinoma of the gallbladder
Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy
A case of perforation of a pancreatic duct by a pancreatic stent during chemoradiotherapy for pancreatic head cancer: a case report
Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy > 40 Gy after systemic treatment
Verrucous carcinoma of the esophagus with complete response after chemoradiotherapy
Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy
Case reports: chemoradiotherapy for locally advanced neuroendocrine carcinoma of the gallbladder
Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy
A case of perforation of a pancreatic duct by a pancreatic stent during chemoradiotherapy for pancreatic head cancer: a case report
Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy > 40 Gy after systemic treatment
Verrucous carcinoma of the esophagus with complete response after chemoradiotherapy
Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy